Abstract
- It has now been established that the new coronavirus infection
worsens the course of many autoimmune systemic diseases, including ankylosing
spondyloarthritis (AS), which adversely affects both the course and outcome of the
disease, leading to early disability. In this regard, it becomes necessary to study the
characteristics of the course of AS and predict the outcome of the disease in patients
with previous COVID-19
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2022 Rakhimova M.B, Akhmedov Kh.S, Khalmetova F.I